HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Kozawa Selected Research

Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)

1/2016cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells.
6/2012Involvement of phosphatidylinositol 3-kinase/Akt on basic fibroblast growth factor-induced glial cell line-derived neurotrophic factor release from rat glioma cells.
4/2012UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells.
6/2009Mechanisms of interleukin-1beta-induced GDNF release from rat glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Kozawa Research Topics

Disease

21Neoplasms (Cancer)
01/2020 - 11/2005
19Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2005
10Pancreatic Neoplasms (Pancreatic Cancer)
07/2016 - 06/2010
8Glioma (Gliomas)
01/2016 - 07/2008
7Colonic Neoplasms (Colon Cancer)
02/2013 - 10/2008
7Thrombosis (Thrombus)
07/2010 - 01/2002
6Bone Resorption
01/2021 - 04/2004
5Carcinogenesis
02/2013 - 09/2009
4Osteoporosis
12/2020 - 01/2002
4Ischemia
10/2014 - 10/2002
4Rheumatoid Arthritis
10/2013 - 04/2004
3Stroke (Strokes)
03/2020 - 11/2009
3Vascular System Injuries
07/2004 - 11/2003
2Cerebral Hemorrhage
01/2022 - 01/2017
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2016
2Low Back Pain (Lumbago)
12/2020 - 08/2020
2Chronic Pain
12/2020 - 08/2020
2Cardiovascular Diseases (Cardiovascular Disease)
03/2020 - 10/2002
2Hypoxia (Hypoxemia)
02/2016 - 09/2006
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2016 - 01/2002
2Inflammation (Inflammations)
06/2015 - 01/2015
2Diabetes Mellitus
01/2015 - 08/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2014 - 11/2009
2Colorectal Neoplasms (Colorectal Cancer)
07/2012 - 06/2011
2Retinoblastoma (Glioblastoma, Retinal)
07/2011 - 03/2010
2Hypercholesterolemia
08/2006 - 07/2004
2Myocardial Infarction
06/2005 - 10/2002
2Ganglion Cysts (Ganglion)
10/2004 - 10/2002
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Postmenopausal Osteoporosis
01/2022
1Fibromyalgia (Fibrositis)
10/2021
1Musculoskeletal Pain
10/2021
1Peripheral Nervous System Diseases (PNS Diseases)
10/2021
1Bone Fractures (Bone Fracture)
01/2021

Drug/Important Bio-Agent (IBA)

17Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017 - 01/2002
15Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
11p38 Mitogen-Activated Protein KinasesIBA
06/2012 - 06/2005
10Phosphotransferases (Kinase)IBA
01/2021 - 09/2009
10ErbB Receptors (EGF Receptor)IBA
12/2011 - 10/2008
8Interleukin-6 (Interleukin 6)IBA
04/2017 - 04/2004
7Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 04/2015
7MitogensIBA
01/2021 - 06/2005
7HSP27 Heat-Shock ProteinsIBA
03/2016 - 11/2005
6JNK Mitogen-Activated Protein KinasesIBA
01/2021 - 03/2010
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 04/2004
5rho-Associated KinasesIBA
01/2021 - 11/2009
5GemcitabineFDA Link
03/2016 - 10/2011
5CytokinesIBA
01/2015 - 04/2004
5Epidermal Growth Factor (EGF)IBA
07/2011 - 10/2008
4Protein Kinase CIBA
01/2021 - 07/2008
4Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
01/2016 - 06/2009
4InterleukinsIBA
01/2016 - 03/2010
4Protein Kinases (Protein Kinase)IBA
10/2014 - 03/2010
4TeaIBA
06/2011 - 04/2007
3Becaplermin (PDGF-BB)FDA Link
07/2016 - 06/2005
3Platelet-Derived Growth FactorIBA
07/2016 - 06/2005
3Pharmaceutical PreparationsIBA
01/2016 - 10/2011
3CollagenIBA
01/2015 - 08/2009
3Serine (L-Serine)FDA Link
11/2011 - 07/2008
3Catechin (Z 7300)IBA
06/2011 - 04/2007
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2009 - 10/2008
3Retinaldehyde (Retinal)IBA
09/2006 - 10/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2004 - 10/2002
3FibrinolysinFDA Link
11/2003 - 01/2002
3Plasminogen Activator Inhibitor 1IBA
07/2003 - 02/2002
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 01/2021
2Serotonin (5 Hydroxytryptamine)IBA
10/2021 - 12/2020
2Duloxetine Hydrochloride (Cymbalta)FDA Link
10/2021 - 12/2020
2Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2021 - 12/2020
2Small Heat-Shock ProteinsIBA
01/2021 - 01/2016
2OsteoprotegerinIBA
01/2021 - 01/2017
2Olive OilIBA
03/2020 - 07/2019
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2020 - 01/2018
2PolyphenolsIBA
07/2019 - 08/2009
2LipidsIBA
01/2018 - 10/2008
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2017 - 01/2013
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2016 - 10/2014
2Factor Xa (Coagulation Factor Xa)IBA
01/2016 - 07/2003
2Midazolam (Versed)FDA LinkGeneric
01/2014 - 06/2011
2Tissue Inhibitor of Metalloproteinase-1IBA
02/2013 - 01/2013
2Mitogen-Activated Protein KinasesIBA
01/2013 - 11/2011
2tyrosine receptor (receptor, tyrosine)IBA
07/2012 - 06/2011
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
06/2012 - 06/2009
2Cyclin D1IBA
07/2011 - 03/2010
2Y 27632IBA
01/2011 - 03/2010
2NF-kappa B (NF-kB)IBA
03/2010 - 06/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2006 - 03/2004
1Amyloid (Amyloid Fibrils)IBA
01/2022
1Estrogens (Estrogen)FDA Link
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Thrombopoietin (c-mpl Ligand)IBA
01/2022
1IncretinsIBA
01/2022
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2022
1Estrogen ReceptorsIBA
01/2022
1Hormones (Hormone)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022

Therapy/Procedure

7Therapeutics
10/2013 - 01/2002
3Drug Therapy (Chemotherapy)
07/2016 - 12/2011
2Intravitreal Injections
09/2006 - 10/2004